NeuroMetrix Stock News

A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It is a measure put in place to help restore and bri

Here are three penny stocks for your watchlist right now The post Hot Penny Stocks to Watch Right Now? 3 For Your List in May appeared first on Penny Stocks to Buy, Picks, News and Information | Penny

Today, investors in NeuroMetrix and NURO stock are cheering an announcement that the FDA has approved the company to market its Quell device. The post Why Is NeuroMetrix (NURO) Stock Up 70% Today?

NeuroMetrix Inc (NASDAQ: NURO) shares are trading higher by 30.10% at $4.06 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid f

NeuroMetrix, Inc. (NASDAQ:NURO ) Q1 2022 Earnings Conference Call April 26, 2022 8:00 AM ET Company Participants Thomas Higgins - Senior Vice President and Chief Financial Officer Shai Gozani - Presid

WOBURN, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2022 first quarter financial results before the opening of the market on A

NeuroMetrix Inc''s (NASDAQ: NURO ) Quell wearable neuromodulation technology will be evaluated for fibromyalgia-like syndrome in individuals with post-acute COVID-19 syndrome (PACS, or "long COVID"). Quell is an advanced, non-invasive neuromodulation technology covered by 22 U.S. utility patents and numerous … Full story available on Benzinga.com

NeuroMetrix press release (NURO): Q4 net loss of $1MRevenue of $1.82M (+0.6% Y/Y).

NeuroMetrix, Inc.'s (NURO) CEO Dr. Shai Gozani on Q4 2021 Results - Earnings Call Transcript

WOBURN, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2021 fourth quarter and full year financial results before the opening of t

NeuroMetrix (NURO) stock is rocketing higher on Tuesday thanks to the FDA granting it Breakthrough Designation for one of its devices.

Nano-cap, NeuroMetrix <> is trading sharply higher in morning hours after announcing that the FDA granted the Breakthrough Designation for its Quell technology designed to…

NeuroMetrix (NURO) +39%. Mainz Biomed MYNZ +26%. Dyne Therapeutics DYN -17%. Allarity Therapeutics (ALLR) -15%.

NeuroMetrix Inc. (NASDAQ: NURO) shot up 35% after announcing that the FDA awarded it Breakthrough Device Designation for its Quell technology. This innovative technology is designed to help reduce se